Stress-induced modulation of the immune response to recombinant hepatitis B vaccine.

Ronald Glaser, Janice K. Kiecolt‐Glaser, Robert H. Bonneau, +3

Psychosomatic Medicine

ImmunologyHepatitis BImmune RegulationVaccine HesitancyImmune System +15

The Novel Tuberculosis Vaccine, AERAS-402, Induces Robust and Polyfunctional CD4 ⁺ and CD8 ⁺ T Cells in Adults

Michèle Tameris, Nazma Mansoor, Sebastian Gelderbloem, +22

American Journal of Respiratory and Critical Care Medicine

An investigation into the health-related quality of life of individuals living with HIV who are receiving HAART

Jennifer Jelsma, Emi Maclean, Jane Hughes, +2

AIDS Care

Novel application of Ki67 to quantify antigen-specific in vitro lymphoproliferation

Andreia Soares, Lerisa Govender, Jane Hughes, +10

Journal of Immunological Methods

Novel application of a whole blood intracellular cytokine detection assay to quantitate specific T-cell frequency in field studies

Willem A. Hanekom, Jane Hughes, Maushumi Mavinkurve, +13

Journal of Immunological Methods

InflammationNovel ApplicationAllergyAutoimmune DiseaseLaboratory Immunology +9

Two loci control tuberculin skin test reactivity in an area hyperendemic for tuberculosis

Aurélie Cobat, Caroline J. Gallant, Leah Simkin, +14

The Journal of Experimental Medicine

Optimization and Interpretation of Serial QuantiFERON Testing to Measure Acquisition of <i>Mycobacterium tuberculosis</i> Infection

Elisa Nemes, Virginie Rozot, Hennie Geldenhuys, +102

American Journal of Respiratory and Critical Care Medicine

Metabolite changes in blood predict the onset of tuberculosis

January Weiner, Jeroen Maertzdorf, Jayne S. Sutherland, +99

Nature Communications

Bacillus Calmette–Guérin (BCG) Revaccination of Adults with Latent <i>Mycobacterium tuberculosis</i> Infection Induces Long-Lived BCG-Reactive NK Cell Responses

Sara Suliman, Hennie Geldenhuys, John L. Johnson, +14

The Journal of Immunology

Clinical ImmunologyBcg VaccinationAdaptive Immune SystemImmunodeficienciesTuberculosis Prevention +16

The Candidate TB Vaccine, MVA85A, Induces Highly Durable Th1 Responses

Michèle Tameris, Hennie Geldenhuys, Angelique Kany Kany Luabeya, +8

PLoS ONE